Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Senior Subordinated Secured Convertible Note
Preferred Stock
Convertible Preferred Stock
Common Stock
Common Stock
Class A and Class B Common Stock
Common Stock
Class A and Class B Common Stock
Senior Subordinated Secured Convertible Note
Additional Paid-in Capital
Additional Paid-in Capital
Senior Subordinated Secured Convertible Note
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2020     120,408 99,002 0       (13,376)    
Beginning balance at Jan. 31, 2020 $ (22,351)   $ 245,970 $ 3 $ 0   $ 50,117   $ (17,957) $ (988) $ (299,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation - equity classified awards 8,990           8,990        
Exercise of stock options (in shares)       1,538              
Exercise of stock options 1,357           1,357        
Issuance of common stock to a third party (in shares)       1,014              
Issuance of common stock to a third party 5,000           5,000        
Other comprehensive loss 686                 686  
Net (loss) income (8,198)                   (8,198)
Ending balance (in shares) at Jul. 31, 2020     120,408 101,554 0       (13,376)    
Ending balance at Jul. 31, 2020 (14,516)   $ 245,970 $ 3 $ 0   65,464   $ (17,957) (302) (307,694)
Beginning balance (in shares) at Apr. 30, 2020     120,408 100,096 0       (13,376)    
Beginning balance at Apr. 30, 2020 (24,830)   $ 245,970 $ 3 $ 0   58,732   $ (17,957) (875) (310,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation - equity classified awards 5,596           5,596        
Exercise of stock options (in shares)       1,458              
Exercise of stock options 1,136           1,136        
Other comprehensive loss 573                 573  
Net (loss) income 3,009                   3,009
Ending balance (in shares) at Jul. 31, 2020     120,408 101,554 0       (13,376)    
Ending balance at Jul. 31, 2020 (14,516)   $ 245,970 $ 3 $ 0   65,464   $ (17,957) (302) (307,694)
Beginning balance (in shares) at Jan. 31, 2021     120,903 109,587 0       (14,131)    
Beginning balance at Jan. 31, 2021 182,733   $ 424,992 $ 4 $ 0   122,061   $ (23,831) 787 (341,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)         18,288            
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 275,954           275,954        
Conversion of Senior subordinated secured convertible notes (in shares)     (120,903)   120,903 9,694          
Conversion of senior subordinated secured convertible notes 0 $ 82,114 $ (424,992)   $ 4   424,988 $ 82,114      
Stock-based compensation - equity classified awards 25,265           25,265        
Reclassification of common stock to class B common stock (in shares)       (117,176) 117,176            
Reclassification of common stock to Class B common stock $ 0     $ (4) $ 4            
Exercise of stock options (in shares) 8,546     7,589 968            
Exercise of stock options $ 16,659           16,659        
Net exercise of common stock warrants (in shares)         230            
Issuance of common stock under deferred stock compensation plan (in shares)         1,770            
Other comprehensive loss (797)                 (797)  
Net (loss) income (47,944)                   (47,944)
Ending balance (in shares) at Jul. 31, 2021     0 0 269,029       (14,131)    
Ending balance at Jul. 31, 2021 533,984   $ 0 $ 0 $ 8   947,041   $ (23,831) (10) (389,224)
Beginning balance (in shares) at Apr. 30, 2021     120,903 115,279 0       (14,131)    
Beginning balance at Apr. 30, 2021 184,299   $ 424,992 $ 4 $ 0   138,724   $ (23,831) 387 (355,977)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)         18,288            
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 275,954           275,954        
Conversion of Senior subordinated secured convertible notes (in shares)     (120,903)   120,903 9,694          
Conversion of senior subordinated secured convertible notes 0 $ 82,114 $ (424,992)   $ 4   424,988 $ 82,114      
Stock-based compensation - equity classified awards 16,609           16,609        
Reclassification of common stock to class B common stock (in shares)       (117,176) 117,176            
Reclassification of common stock to Class B common stock 0     $ (4) $ 4            
Exercise of stock options (in shares)       1,897 968            
Exercise of stock options 8,652           8,652        
Net exercise of common stock warrants (in shares)         230            
Issuance of common stock under deferred stock compensation plan (in shares)         1,770            
Other comprehensive loss (397)                 (397)  
Net (loss) income (33,247)                   (33,247)
Ending balance (in shares) at Jul. 31, 2021     0 0 269,029       (14,131)    
Ending balance at Jul. 31, 2021 $ 533,984   $ 0 $ 0 $ 8   $ 947,041   $ (23,831) $ (10) $ (389,224)